Home  |  Current Issue  |  All Issues  |  Online Submission  |  Subscription  |  Contact Us
Article Search Advanced
  Journal Online
  Ahead of publication
  Current issue
  All issues
  Home on Elsevier
  Manuscript Submission
  Online submission
  Online review
  Instruction for Authors
  Instruction for Reviewers
  Journal Home
  About the journal
  About the chief editor
  Editorial board
  Subscription
  Advertising and reprints
  Acknowledgements to
  reviewers
  Indexed/Abstracted
  Copyright transfer
  Contact us
  Links
PubMed/MEDLINE
Thomson Reuters
ResearchGate
Open J-Gate
SCImago
BioInfoBank Library
Freemedicaljournals
Pancreatology
Digestive Surgery
Eastliver
Welcome to Hepatobiliary & Pancreatic Diseases International
Hepatobiliary & Pancreatic Diseases International (HBPD INT) (ISSN 1499-3872 / CN 33-1391/R) a bimonthly journal published by First Affiliated Hospital, Zhejiang University School of Medicine, China. It publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases. Papers cover the medical, surgical, radiological, pathological, biochemical, physiological and historical aspects of the subject areas under the headings Liver, Biliary, Pancreas, Transplantation, Research, Special Reports, Editorials, Review Articles, Brief Communications, Clinical Summary, Clinical Images and Case Reports. It also deals with the basic sciences and experimental work. The journal is abstracted and indexed in SCI-E, IM/MEDLINE, EMBASE/EM, CA, Scopus, ScienceDirect, etc.

Vol 14, No 4, p 337-448
15 August 2015
Current Issue
Chief Editor: Shu-Sen Zheng
Impact factor: 1.517
(ISI 2014 JCR)
  Hot Articles more>>     
 
  Current Issue     2015, Volume 14, No. 4 more>>     
Minimally invasive spleen-preserving distal pancreatectomy: Does splenic vessel preservation have better postoperative outcomes? A systematic review and meta-analysis
Advanced therapeutic strategies for HBV-related acute-on-chronic liver failure
Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
Clinical factors affecting rejection rates in liver transplantation
Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients
  NEWS
· 2014 SCI impact factor is available now
· 2014 The 3rd editorial committee meeting of Hepatobiliary & Pancreatic Diseases International
· 2013 SCI impact factor is available now
· Authorship in Hepatobilary & Pancreatic Diseases International
· 2012 SCI impact factor is available now
· Website is updating, we will release all published papers as soon as possible.
· 2012 The 2nd editorial committee meeting of HBPD INT held in Hangzhou, China
more>>     

ScholarOne Manuscripts Log In

User ID:

Password:

Forgot your password?

Enter your e-mail address to receive an e-mail with your account information.

  Submission Guidance
  Top cited articles
· NEW: Cited articles published in 2012
· NEW: Cited articles published in 2013
more>>  
  Top downloaded articles
more>>  
  Services
Sign up for e-alerts
Web feed
hbpdje@mail.hz.zj.cn
  hbpdje@zju.edu.cn


Copyright © Official Publication of First Affiliated Hospital
Official Publication of First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
ZJICP: 05050873